{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:25:56Z","timestamp":1786638356096,"version":"build-2736575974"},"reference-count":108,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hypocellular bone marrow failure (BMF) may be acquired due to immune-mediated disease, the prototype being immune aplastic anemia (IAA), or inherited, due to germ line defects in genes important for hematopoietic stem cell function and maintenance (inherited BMF syndromes [IBMFS]). Proper diagnosis of the underlying etiology of hypocellular BMF, particularly distinguishing IAA, myelodysplastic syndrome (MDS; most relevant in this setting is hypoplastic MDS), and the IBMFS, is important given the differences in clinical management. Clonal hematopoiesis (CH), in this context comprising somatic mutations or chromosomal abnormalities, is incorporated into standard algorithms for classification, risk stratification, and treatment decisions for hematologic malignancies, but the clinical significance in BMF is not well established. Disease-specific clonal signatures have been reported across the BMF spectrum, and here, we present how distinct patterns of CH can aid in distinguishing different etiologies of hypocellular BMF. In addition, detection of somatic alterations in many BMF disorders can estimate risk for secondary myeloid neoplasms, guide surveillance and, in some instances, allow for early therapeutic intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025029923","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:54:58Z","timestamp":1778165698000},"page":"818-830","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["How I utilize somatic alterations in the diagnosis, risk stratification, and therapy of hypocellular bone marrow failure"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-5926","authenticated-orcid":false,"given":"Emma M.","family":"Groarke","sequence":"first","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-4588","authenticated-orcid":false,"given":"Fernanda","family":"Gutierrez-Rodrigues","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2974-7701","authenticated-orcid":false,"given":"Bhavisha A.","family":"Patel","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"17","key":"2026081311213270000_bib1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"2026081311213270000_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.leu.2405076","article-title":"Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-\/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies","volume":"22","author":"Huang","year":"2008","journal-title":"Leukemia"},{"issue":"11","key":"2026081311213270000_bib3","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.3324\/haematol.2015.130112","article-title":"Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes","volume":"100","author":"Nazha","year":"2015","journal-title":"Haematologica"},{"issue":"17","key":"2026081311213270000_bib4","first-page":"2100","article-title":"Differential diagnosis of bone marrow failure syndromes guided by machine learning","volume":"141","author":"Gutierrez-Rodrigues","year":"2023","journal-title":"Blood"},{"key":"2026081311213270000_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra2101920","article-title":"Somatic mutations in \u201cBenign\u201d disease","author":"Mustjoki","year":"2021;384:2039-2052","journal-title":"New Engl J Med"},{"issue":"7","key":"2026081311213270000_bib6","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"2026081311213270000_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2026081311213270000_bib8","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"2026081311213270000_bib9","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.2024025771","article-title":"How I manage patients with unexplained cytopenia","volume":"145","author":"Malcovati","year":"2025","journal-title":"Blood"},{"issue":"2","key":"2026081311213270000_bib10","doi-asserted-by":"crossref","first-page":"101279","DOI":"10.1016\/j.beha.2021.101279","article-title":"Somatic mosaicism in inherited bone marrow failure syndromes","volume":"34","author":"Gutierrez-Rodrigues","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"2026081311213270000_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.stem.2023.01.006","article-title":"Clonal hematopoiesis driven by chromosome 1q\/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia","volume":"30","author":"Sebert","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"23","key":"2026081311213270000_bib12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood.2024025023","article-title":"Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations","volume":"144","author":"Gutierrez-Rodrigues","year":"2024","journal-title":"Blood"},{"issue":"1","key":"2026081311213270000_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41408-025-01309-6","article-title":"Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency","volume":"15","author":"Kotmayer","year":"2025","journal-title":"Blood Cancer J"},{"issue":"9","key":"2026081311213270000_bib14","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41375-022-01636-8","article-title":"Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia","volume":"36","author":"Groarke","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"2026081311213270000_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/bloodadvances.2023011165","article-title":"Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy","volume":"8","author":"Yu","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"2026081311213270000_bib16","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat Commun"},{"issue":"10","key":"2026081311213270000_bib17","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","article-title":"Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/SAMD9L syndromes","volume":"27","author":"Sahoo","year":"2021","journal-title":"Nat Med"},{"issue":"10","key":"2026081311213270000_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41576-019-0139-x","article-title":"Somatic genetic rescue in Mendelian haematopoietic diseases","volume":"20","author":"Revy","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"4","key":"2026081311213270000_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2017-08-801985","article-title":"Somatic mutations and clonal hematopoiesis in congenital neutropenia","volume":"131","author":"Xia","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2026081311213270000_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/hematology.2019000019","article-title":"Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome","volume":"2019","author":"Durrani","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"2026081311213270000_bib21","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/bjh.19323","article-title":"Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: results from a multicentre registry","volume":"204","author":"Maeda","year":"2024","journal-title":"Br J Haematol"},{"issue":"10","key":"2026081311213270000_bib22","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/s41375-019-0457-1","article-title":"Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome","volume":"33","author":"Bono","year":"2019","journal-title":"Leukemia"},{"issue":"27","key":"2026081311213270000_bib23","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2016.66.9705","article-title":"Considering bone marrow blasts from nonerythroid cellularity improves the prognostic evaluation of myelodysplastic syndromes","volume":"34","author":"Arenillas","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"2026081311213270000_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/ejh.13913","article-title":"Long-term outcomes of aplastic anemia with cytogenetic abnormalities at diagnosis","volume":"110","author":"Li","year":"2023","journal-title":"Eur J Haematol"},{"issue":"12","key":"2026081311213270000_bib25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3324\/haematol.2011.061127","article-title":"Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation","volume":"97","author":"Hosokawa","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"2026081311213270000_bib26","first-page":"312","article-title":"Genome sequencing in the management of myelodysplastic syndromes and related disorders","volume":"110","author":"Cazzola","year":"2025","journal-title":"Haematologica"},{"issue":"1","key":"2026081311213270000_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"2026081311213270000_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1200\/JCO.22.00710","article-title":"Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"41","author":"Gurnari","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026081311213270000_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41375-022-01723-w","article-title":"Molecular landscape of immune pressure and escape in aplastic anemia","volume":"37","author":"Pagliuca","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"2026081311213270000_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault de Latour","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"2026081311213270000_bib31","doi-asserted-by":"crossref","first-page":"101280","DOI":"10.1016\/j.beha.2021.101280","article-title":"Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome","volume":"34","author":"Karantanos","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"2026081311213270000_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2016-01-636381","article-title":"Clonal hematopoiesis in acquired aplastic anemia","volume":"128","author":"Ogawa","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2026081311213270000_bib33","doi-asserted-by":"crossref","first-page":"EVIDoa2500171","DOI":"10.1056\/EVIDoa2500171","article-title":"Clonal Selection and Evolution after Treatment of Severe Aplastic Anemia","volume":"5","author":"Gutierrez-Rodrigues","year":"2026","journal-title":"NEJM Evid"},{"issue":"5","key":"2026081311213270000_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood.2022018221","article-title":"Germ line DDX41 mutations define a unique subtype of myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"issue":"8","key":"2026081311213270000_bib35","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3324\/haematol.2011.048215","article-title":"The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells","volume":"97","author":"Pu","year":"2012","journal-title":"Haematologica"},{"issue":"16","key":"2026081311213270000_bib36","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/bloodadvances.2021004201","article-title":"The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis","volume":"5","author":"Shah","year":"2021","journal-title":"Blood Adv"},{"issue":"11","key":"2026081311213270000_bib37","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1038\/s41375-021-01190-9","article-title":"Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia","volume":"35","author":"Fattizzo","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"2026081311213270000_bib38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3324\/haematol.2009.017889","article-title":"Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine","volume":"95","author":"Scheinberg","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"2026081311213270000_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.2019000940","article-title":"Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"136","author":"Sun","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2026081311213270000_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.2021012130","article-title":"Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study","volume":"139","author":"Patel","year":"2022","journal-title":"Blood"},{"issue":"17","key":"2026081311213270000_bib41","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood-2014-05-574889","article-title":"Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome","volume":"124","author":"Kulasekararaj","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2026081311213270000_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","journal-title":"N Engl J Med"},{"issue":"24","key":"2026081311213270000_bib43","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/blood.2019000478","article-title":"Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag","volume":"133","author":"Winkler","year":"2019","journal-title":"Blood"},{"issue":"17","key":"2026081311213270000_bib44","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2017-02-767731","article-title":"Origins of myelodysplastic syndromes after aplastic anemia","volume":"130","author":"Negoro","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2026081311213270000_bib46","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1182\/hematology.2023000488","article-title":"When to consider inherited marrow failure syndromes in adults","volume":"2023","author":"Gutierrez-Rodrigues","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"2026081311213270000_bib47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamaoncol.2015.6053","article-title":"Somatic mosaic mutations in PPM1D and TP53 in the blood of women with ovarian carcinoma","volume":"2","author":"Swisher","year":"2016","journal-title":"JAMA Oncol"},{"issue":"8","key":"2026081311213270000_bib48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.2022016508","article-title":"Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes","volume":"140","author":"McReynolds","year":"2022","journal-title":"Blood"},{"issue":"24","key":"2026081311213270000_bib49","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood.2022015790","article-title":"Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages","volume":"140","author":"Feurstein","year":"2022","journal-title":"Blood"},{"issue":"2-3","key":"2026081311213270000_bib50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000069805","article-title":"Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction","volume":"98","author":"Gross","year":"2002","journal-title":"Cytogenet Genome Res"},{"issue":"3","key":"2026081311213270000_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000484749","article-title":"Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance","volume":"5","author":"Lo Ten Foe","year":"1997","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"2026081311213270000_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/11956","article-title":"Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism","volume":"22","author":"Waisfisz","year":"1999","journal-title":"Nat Genet"},{"issue":"5","key":"2026081311213270000_bib53","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1073\/pnas.051609898","article-title":"Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells","volume":"98","author":"Gregory","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2026081311213270000_bib54","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1182\/blood-2005-07-2638","article-title":"Natural gene therapy in monozygotic twins with Fanconi anemia","volume":"107","author":"Mankad","year":"2006","journal-title":"Blood"},{"issue":"5","key":"2026081311213270000_bib55","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/517616","article-title":"Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype","volume":"80","author":"Kalb","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2026081311213270000_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000366251","article-title":"Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes","volume":"144","author":"Fargo","year":"2014","journal-title":"Cytogenet Genome Res"},{"issue":"5","key":"2026081311213270000_bib57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/bloodadvances.2016000943","article-title":"Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia","volume":"1","author":"Reina-Castill\u00f3n","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"2026081311213270000_bib58","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00277-020-03954-2","article-title":"Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization","volume":"99","author":"Nicoletti","year":"2020","journal-title":"Ann Hematol"},{"issue":"3","key":"2026081311213270000_bib59","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2004-05-1852","article-title":"Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA\/BRCA pathway","volume":"105","author":"Soulier","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2026081311213270000_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mgg3.350","article-title":"Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype","volume":"6","author":"Asur","year":"2018","journal-title":"Mol Genet Genomic Med"},{"issue":"18","key":"2026081311213270000_bib61","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1093\/hmg\/ddv227","article-title":"AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia","volume":"24","author":"Virts","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2026081311213270000_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng1942","article-title":"Fanconi anemia is associated with a defect in the BRCA2 partner PALB2","volume":"39","author":"Xia","year":"2007","journal-title":"Nat Genet"},{"issue":"15","key":"2026081311213270000_bib63","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","article-title":"Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions","volume":"117","author":"Quentin","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2026081311213270000_bib64","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/pbc.24168","article-title":"Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML","volume":"59","author":"Rochowski","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2026081311213270000_bib65","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood.2021011980","article-title":"Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue","volume":"139","author":"Sharma","year":"2022","journal-title":"Blood"},{"issue":"3","key":"2026081311213270000_bib66","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1172\/JCI91161","article-title":"Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations","volume":"127","author":"Maryoung","year":"2017","journal-title":"J Clin Invest"},{"issue":"7","key":"2026081311213270000_bib67","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41436-018-0385-x","article-title":"Pathogenic TERT promoter variants in telomere diseases","volume":"21","author":"Gutierrez-Rodrigues","year":"2019","journal-title":"Genet Med"},{"issue":"18","key":"2026081311213270000_bib68","doi-asserted-by":"crossref","first-page":"e147598","DOI":"10.1172\/JCI147598","article-title":"Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders","volume":"131","author":"Schratz","year":"2021","journal-title":"J Clin Invest"},{"issue":"6","key":"2026081311213270000_bib69","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/hmg\/ddaa011","article-title":"NHP2 deficiency impairs rRNA biogenesis and causes pulmonary fibrosis and H\u00f8yeraal-Hreidarsson syndrome","volume":"29","author":"Benyelles","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2026081311213270000_bib70","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ajh.24552","article-title":"Clonal hematopoiesis in patients with dyskeratosis congenita","volume":"91","author":"Perdigones","year":"2016","journal-title":"Am J Hematol"},{"issue":"8","key":"2026081311213270000_bib71","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41375-018-0125-x","article-title":"Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita","volume":"32","author":"Kirschner","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"2026081311213270000_bib72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ajhg.2012.01.004","article-title":"Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita","volume":"90","author":"Jongmans","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2026081311213270000_bib73","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1378\/chest.14-1947","article-title":"Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis","volume":"147","author":"Alder","year":"2015","journal-title":"Chest"},{"issue":"9","key":"2026081311213270000_bib74","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1182\/blood.2025031248","article-title":"Somatic genetic rescue in ZCCHC8-associated telomere biology disorders","volume":"147","author":"De Tocqueville","year":"2026","journal-title":"Blood"},{"issue":"22","key":"2026081311213270000_bib75","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.2019003264","article-title":"Cancer spectrum and outcomes in the Mendelian short telomere syndromes","volume":"135","author":"Schratz","year":"2020","journal-title":"Blood"},{"issue":"8","key":"2026081311213270000_bib76","doi-asserted-by":"crossref","first-page":"e181659","DOI":"10.1172\/JCI181659","article-title":"ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders","volume":"135","author":"Sande","year":"2025","journal-title":"J Clin Invest"},{"issue":"4","key":"2026081311213270000_bib77","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/leu.2008.369","article-title":"The isochromosome i(7)(q10) carrying c.258+2t&gt;c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome","volume":"23","author":"Minelli","year":"2009","journal-title":"Leukemia"},{"issue":"1","key":"2026081311213270000_bib78","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1038\/s41467-021-24999-5","article-title":"Somatic genetic rescue of a germline ribosome assembly defect","volume":"12","author":"Tan","year":"2021","journal-title":"Nat Commun"},{"issue":"21","key":"2026081311213270000_bib79","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1182\/blood.2021010913","article-title":"Somatic uniparental disomy mitigates the most damaging EFL1 allele combination in Shwachman-Diamond syndrome","volume":"138","author":"Lee","year":"2021","journal-title":"Blood"},{"issue":"12","key":"2026081311213270000_bib80","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.3324\/haematol.2017.166678","article-title":"Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient","volume":"102","author":"Venugopal","year":"2017","journal-title":"Haematologica"},{"issue":"23","key":"2026081311213270000_bib81","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1182\/blood.2021013507","article-title":"Studies of a mosaic patient with DBA and chimeric mice reveal erythroid cell-extrinsic contributions to erythropoiesis","volume":"139","author":"Doty","year":"2022","journal-title":"Blood"},{"issue":"12","key":"2026081311213270000_bib82","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.3324\/haematol.2018.200683","article-title":"Somatic reversion events point towards RPL4 as a novel disease gene in a condition resembling Diamond-Blackfan anemia","volume":"103","author":"Jongmans","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"2026081311213270000_bib83","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/bjh.15688","article-title":"Spontaneous remission in a Diamond-Blackfan anaemia patient due to a revertant uniparental disomy ablating a de novo RPS19 mutation","volume":"185","author":"Garelli","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"2026081311213270000_bib84","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood.2020005538","article-title":"Somatic genetic rescue in hematopoietic cells in GATA2 deficiency","volume":"136","author":"Catto","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2026081311213270000_bib85","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/bloodadvances.2021005065","article-title":"ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome","volume":"6","author":"West","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"2026081311213270000_bib86","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3324\/haematol.2022.282250","article-title":"Somatic genetic alterations predict hematological progression in GATA2 deficiency","volume":"108","author":"Largeaud","year":"2023","journal-title":"Haematologica"},{"issue":"23","key":"2026081311213270000_bib87","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1182\/blood.2021012781","article-title":"Association of unbalanced translocation der(1;7) with germline GATA2 mutations","volume":"138","author":"Kozyra","year":"2021","journal-title":"Blood"},{"issue":"10","key":"2026081311213270000_bib88","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.3324\/haematol.2020.253070","article-title":"First description of revertant mosaicism in familial platelet disorder with predisposition to acute myelogenous leukemia: correlation with the clinical phenotype","volume":"105","author":"Glembotsky","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"2026081311213270000_bib89","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/bloodadvances.2023011165","article-title":"Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy","volume":"8","author":"Yu","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"2026081311213270000_bib90","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2017.167726","article-title":"Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation","volume":"102","author":"Kanagal-Shamanna","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"2026081311213270000_bib91","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv"},{"issue":"23","key":"2026081311213270000_bib92","first-page":"2853","article-title":"The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia","volume":"141","author":"Hakkarainen","year":"2023","journal-title":"Blood"},{"key":"2026081311213270000_bib93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clim.2019.04.008","article-title":"Two paternal mosaicism of mutation in ELANE causing severe congenital neutropenia exhibit normal neutrophil morphology and ROS production","volume":"203","author":"Liu","year":"2019","journal-title":"Clin Immunol"},{"issue":"5","key":"2026081311213270000_bib94","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10875-015-0165-1","article-title":"Mosaicism of an ELANE mutation in an asymptomatic mother in a familial case of cyclic neutropenia","volume":"35","author":"Hirata","year":"2015","journal-title":"J Clin Immunol"},{"issue":"14","key":"2026081311213270000_bib95","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2013-11-538025","article-title":"Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis","volume":"123","author":"Skokowa","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2026081311213270000_bib96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1182\/blood-2006-02-004275","article-title":"Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey","volume":"109","author":"Germeshausen","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2026081311213270000_bib97","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/hematology.2022000393","article-title":"Modern management of Fanconi anemia","volume":"2022","author":"Dufour","year":"2022","journal-title":"Hematology"},{"issue":"7","key":"2026081311213270000_bib98","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0301-472X(02)00815-9","article-title":"Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study","volume":"30","author":"Dror","year":"2002","journal-title":"Exp Hematol"},{"issue":"1","key":"2026081311213270000_bib99","doi-asserted-by":"crossref","first-page":"101252","DOI":"10.1016\/j.beha.2021.101252","article-title":"Molecular alterations governing predisposition to myelodysplastic syndromes: insights from Shwachman-Diamond syndrome","volume":"34","author":"Shimamura","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"2026081311213270000_bib100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2012.09033.x","article-title":"Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis","volume":"157","author":"Pressato","year":"2012","journal-title":"Br J Haematol"},{"issue":"26","key":"2026081311213270000_bib101","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2026081311213270000_bib102","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"2026081311213270000_bib103","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1182\/blood-2025-4993","article-title":"Characterization of the germline and somatic mutation profile of Diamond-Blackfan anemia","volume":"146","author":"Catto","year":"2025","journal-title":"Blood"},{"issue":"suppl 1","key":"2026081311213270000_bib104","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/blood-2025-746","article-title":"Polyclonal somatic gene rescue via uniparental disomy confers multilineage hematopoietic potential in treatment-independent patients with DBA syndrome","volume":"146","author":"Yoshida","year":"2025","journal-title":"Blood"},{"issue":"11","key":"2026081311213270000_bib105","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"25","key":"2026081311213270000_bib106","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood.2023019746","article-title":"Natural history study of patients with familial platelet disorder with associated myeloid malignancy","volume":"142","author":"Cunningham","year":"2023","journal-title":"Blood"},{"issue":"8","key":"2026081311213270000_bib107","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.bbmt.2020.04.029","article-title":"Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome","volume":"26","author":"Myers","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"2026081311213270000_bib108","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ajh.25810","article-title":"Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: a retrospective analysis on behalf of EBMT group","volume":"95","author":"Giardino","year":"2020","journal-title":"Am J Hematol"},{"issue":"13","key":"2026081311213270000_bib109","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood.2022017739","article-title":"Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances","volume":"141","author":"Reilly","year":"2023","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/7\/818\/2537540\/blood_bld-2025-029923-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/7\/818\/2537540\/blood_bld-2025-029923-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:21:48Z","timestamp":1786634508000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/7\/818\/568215\/How-I-utilize-somatic-alterations-in-the-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":108,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025029923","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,13]]},"published":{"date-parts":[[2026,8,13]]}}}